The Conversation (0)
- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Trending
Trending Articles
Trending Press Releases
Trending Companies
Trending Reports
Resource
Popular Lists
Investing Ideas
Outlook Reports
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
Investing Guides
Tech
Popular Lists
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
Investing Ideas
Outlook Reports
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
Investing Guides
Life Science
Popular Lists
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
Outlook Reports
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Investing Guides
CSE: 2018-0527 – New Listing – FSD Pharma Inc. (HUGE)
May. 28, 2018 02:27PM PST
Cannabis Investing News
The Class B Subordinate Voting Shares of FSD Pharma Inc. have been approved for listing on the CSE.
The Class B Subordinate Voting Shares of FSD Pharma Inc. have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on the trading date.
FSD Pharma, owns, through its wholly-owned subsidiary FV Pharma Inc., a license to produce marijuana under the Access to Cannabis for Medical Purposes Regulations (ACMPR) which was originally granted on October 13, 2017. Headquartered at the former Kraft plant in Cobourg, Ontario, approximately an hour’s drive from Toronto, FSD Pharma’s management’s mission is to transform the facility into the largest hydroponic indoor cannabis facility in the world. FSD Pharma intends to target all legal aspects of the cannabis industry, including cultivation, processing, manufacturing, extracts and research and development.
________________________
Les actions à droit de vote subalterne de catégorie B ont été approuvées pour inscription à la cote du CSE.
Les documents d’inscription et de divulgation seront disponibles sur www.thecse.com à la date de négociation.
FSD Pharma détient, par l’entremise de sa filiale en propriété exclusive, FV Pharma Inc., une licence de production de marijuana en vertu du Règlement sur l’accès au cannabis à des fins médicales (ACMPR) initialement accordé le 13 octobre 2017. Son siège social est situé à À Cobourg, en Ontario, à environ une heure de route de Toronto, la direction de FSD Pharma a pour mission de transformer l’installation en la plus grande installation de culture hydroponique intérieure de cannabis au monde. FSD Pharma a l’intention de cibler tous les aspects légaux de l’industrie du cannabis, y compris la culture, la transformation, la fabrication, les extraits et la recherche et le développement.
| Issuer/Émetteur: | FSD Pharma Inc. |
| Security Type/Titre: | Class B Subordinate Voting Shares/ Actions à droit de vote subalterne de catégorie B |
| Symbol(s)/Symbole(s): | HUGE |
| Number of securities issued and outstanding/ Titres émis et en circulation: | 1 319 600 458 |
| Number of Securities reserved for issuance/ Titres réservés pour émission: | 212 242 457 |
| CSE Sector/Catégorie: | Life Sciences/ Sciences biologiques |
| CUSIP: | 35954B 10 7 |
| ISIN: | CA 35954B 10 7 6 |
| Boardlot/Quotité: | 500 |
| Trading Currency/Monnaie de négociation: | CDN$/$CDN |
| Trading Date/Date de negociation: | Le 29 mai/May 2018 |
| Other Exchanges/Autres marches: | N/A |
| Fiscal Year end /Clôture de l’exercice financier: | December 31/Le 31 décembre |
| Transfer Agent/Agent des transferts: | Computershare Investor Services Inc. |
If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com
Pour toute question, pour obtenir de l’information supplémentaire veuillez communiquer avec le service des inscriptions au 416 367-7340 ou par courriel à l’adresse: Listings@thecse.com
Source: globenewswire.com
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.